JP2022537178A - プレボテラ調製物ならびに慢性閉塞性肺疾患（ｃｏｐｄ）および他の肺状態の治療 - Google Patents

プレボテラ調製物ならびに慢性閉塞性肺疾患（ｃｏｐｄ）および他の肺状態の治療 Download PDF

Info

Publication number
JP2022537178A
JP2022537178A JP2021574909A JP2021574909A JP2022537178A JP 2022537178 A JP2022537178 A JP 2022537178A JP 2021574909 A JP2021574909 A JP 2021574909A JP 2021574909 A JP2021574909 A JP 2021574909A JP 2022537178 A JP2022537178 A JP 2022537178A
Authority
JP
Japan
Prior art keywords
prevotella
histicola
melaninogenica
mammal
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021574909A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022537178A5 (cg-RX-API-DMAC10.html
Inventor
ヴィーナ タネハ
Original Assignee
メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ filed Critical メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ
Publication of JP2022537178A publication Critical patent/JP2022537178A/ja
Publication of JP2022537178A5 publication Critical patent/JP2022537178A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Environmental Sciences (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2021574909A 2019-06-17 2020-06-17 プレボテラ調製物ならびに慢性閉塞性肺疾患（ｃｏｐｄ）および他の肺状態の治療 Pending JP2022537178A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962862186P 2019-06-17 2019-06-17
US62/862,186 2019-06-17
PCT/US2020/038084 WO2020257248A1 (en) 2019-06-17 2020-06-17 Prevotella preparations and treating chronic obstructive pulmonary disease (copd) and other lung conditions

Publications (2)

Publication Number Publication Date
JP2022537178A true JP2022537178A (ja) 2022-08-24
JP2022537178A5 JP2022537178A5 (cg-RX-API-DMAC10.html) 2023-05-09

Family

ID=74037580

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021574909A Pending JP2022537178A (ja) 2019-06-17 2020-06-17 プレボテラ調製物ならびに慢性閉塞性肺疾患（ｃｏｐｄ）および他の肺状態の治療

Country Status (11)

Country Link
US (1) US20220296657A1 (cg-RX-API-DMAC10.html)
EP (1) EP3983067A4 (cg-RX-API-DMAC10.html)
JP (1) JP2022537178A (cg-RX-API-DMAC10.html)
KR (1) KR20220024466A (cg-RX-API-DMAC10.html)
CN (1) CN114340732A (cg-RX-API-DMAC10.html)
AU (1) AU2020295393A1 (cg-RX-API-DMAC10.html)
BR (1) BR112021025416A2 (cg-RX-API-DMAC10.html)
CA (1) CA3143597A1 (cg-RX-API-DMAC10.html)
CO (1) CO2022000029A2 (cg-RX-API-DMAC10.html)
MX (1) MX2021015711A (cg-RX-API-DMAC10.html)
WO (1) WO2020257248A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220031765A1 (en) * 2018-11-30 2022-02-03 Ospedale San Raffaele S.R.L. Bacterial strains for medical uses
EP4297762A1 (en) * 2021-02-26 2024-01-03 Evelo Biosciences, Inc. Compositions and methods for reducing cytokine expression
WO2022187064A1 (en) * 2021-03-01 2022-09-09 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2023146843A1 (en) * 2022-01-25 2023-08-03 Evelo Biosciences, Inc. Extracellular vesicle compositions and methods of use
WO2023200837A1 (en) * 2022-04-13 2023-10-19 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
US20250325598A1 (en) * 2022-05-06 2025-10-23 The Regents Of The University Of Colorado, A Body Corporate Immunobiotics for preventing bacterial pneumonia and methods of using the same
WO2024097250A1 (en) * 2022-10-31 2024-05-10 The Trustees Of Columbia University In The City Of New York Polymeric carrier for probiotics

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007514738A (ja) * 2003-12-17 2007-06-07 エヌ．ブイ．・ヌートリシア 乳酸産生菌及び肺機能
JP2014196260A (ja) * 2013-03-29 2014-10-16 公立大学法人奈良県立医科大学 慢性閉塞性肺疾患の予防又は治療用組成物
WO2018158306A1 (en) * 2017-02-28 2018-09-07 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
WO2019004668A1 (ko) * 2017-06-30 2019-01-03 주식회사 엠디헬스케어 프로테우스 속 세균 유래 나노소포 및 이의 용도
WO2019051381A1 (en) * 2017-09-08 2019-03-14 Evelo Biosciences, Inc. EXTRACELLULAR VESICLES FROM PREVOTELLA

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965787A (en) 1995-08-31 1999-10-12 Mayo Foundation For Medical Education And Research HLA-DRBI peptides with specific binding affinity for HLA-DQ molecules: prevention and treatment of rheumatoid arthritis
US20040131614A1 (en) * 2002-07-19 2004-07-08 Abbott Biotechnology Ltd. Treatment of pulmonary disorders using TNFalpha inhibitor
RU2009133376A (ru) 2007-03-27 2011-05-10 Дзе Проктер Энд Гэмбл Компани (US) Способы и наборы для введения пробиотиков
WO2011053653A2 (en) * 2009-10-30 2011-05-05 Mayo Foundation For Medical Education And Research Prevotella histicola preparations and the treatment of autoimmune conditions
US10465224B2 (en) * 2015-02-03 2019-11-05 Mayo Foundation For Medical Education And Research Methods and materials for assessing and treating arthritis
KR20250161669A (ko) * 2015-09-09 2025-11-17 레비비코르 인코포레이션 이종 장기이식을 위한 멀티-형질전환 피그
US20220031765A1 (en) * 2018-11-30 2022-02-03 Ospedale San Raffaele S.R.L. Bacterial strains for medical uses

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007514738A (ja) * 2003-12-17 2007-06-07 エヌ．ブイ．・ヌートリシア 乳酸産生菌及び肺機能
JP2014196260A (ja) * 2013-03-29 2014-10-16 公立大学法人奈良県立医科大学 慢性閉塞性肺疾患の予防又は治療用組成物
WO2018158306A1 (en) * 2017-02-28 2018-09-07 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
WO2019004668A1 (ko) * 2017-06-30 2019-01-03 주식회사 엠디헬스케어 프로테우스 속 세균 유래 나노소포 및 이의 용도
WO2019051381A1 (en) * 2017-09-08 2019-03-14 Evelo Biosciences, Inc. EXTRACELLULAR VESICLES FROM PREVOTELLA

Also Published As

Publication number Publication date
EP3983067A4 (en) 2023-06-14
AU2020295393A1 (en) 2022-01-06
CN114340732A (zh) 2022-04-12
EP3983067A1 (en) 2022-04-20
CA3143597A1 (en) 2020-12-24
US20220296657A1 (en) 2022-09-22
BR112021025416A2 (pt) 2022-02-22
KR20220024466A (ko) 2022-03-03
MX2021015711A (es) 2022-02-03
WO2020257248A1 (en) 2020-12-24
CO2022000029A2 (es) 2022-04-08

Similar Documents

Publication Publication Date Title
US20220296657A1 (en) Prevotella preparations and treating chronic obstructive pulmonary disease (copd) and other lung conditions
JP7797208B2 (ja) プレボテラ（Ｐｒｅｖｏｔｅｌｌａ）を使用してＴＨ２媒介性状態を処置する組成物及び方法
US11058732B2 (en) Compositions comprising bacterial strains
EP2590662B1 (fr) Complexe macromoleculaire provenant de bifidobacterium longum et utilisation dudit complexe pour prevenir et traiter les rhumatismes inflammatoires
Marcotte et al. Oral microbial ecology and the role of salivary immunoglobulin A
EP3204024B1 (en) Compositions comprising bacterial strains
TWI797058B (zh) 包含細菌菌株之組合物
TWI733676B (zh) 包含細菌菌株之組合物
US6433013B1 (en) Composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease
JP2018532814A (ja) 細胞の酸化還元レベルの制御
KR20050109928A (ko) 유산균으로부터 유래된 소염 활성
EP1229930A1 (en) Compositions and methods for treatment of allergic disorders
US20230355689A1 (en) Solid dosage forms containing bacteria and microbial extracellular vesicles
JP2018503597A5 (cg-RX-API-DMAC10.html)
JP2001523249A (ja) 特異的免疫寛容を誘導するための抗原と粘膜結合成分の組合せ
WO2005014014A1 (en) Method for inhibiting bacterial colonisation
WO2004071520A1 (ja) 免疫機能改善を目的としたビフィズス菌製剤
JP2022155522A (ja) 免疫機能低下抑制剤及び免疫機能の低下抑制方法
US20100303861A1 (en) Live Attenuated Vaccine Strain for Prevention of Tularemia
AU782689B2 (en) Compositions and methods for treatment of allergic disorders
PODOPRIGORA The role of microbial factors in non-specific resistance of the host to infection
HK1240831B (en) Compositions comprising bacterial strains
HK1240831A1 (en) Compositions comprising bacterial strains

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220307

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230426

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230426

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230627

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240328

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240820

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241112

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250317